Periodontitis

Periodontitis is a chronic, inflammatory, and infectious disease of the periodontium, which includes the gingiva, periodontal ligament, cementum, and alveolar bone. It is initiated by the accumulation of dental plaque, a biofilm composed of bacteria, salivary glycoproteins, and extracellular polysaccharides, on the tooth surface. The disease progresses from reversible gingivitis to irreversible destruction of the periodontal attachment apparatus, leading to clinical attachment loss, periodontal pocket formation, gingival recession, and ultimately tooth loss. Periodontitis is classified into four stages (Stage 1: gingivitis only; Stage 2: early periodontitis with <25% attachment loss; Stage 3: moderate periodontitis with 25-50% attachment loss; Stage 4: advanced periodontitis with >50% attachment loss) and is further graded by the rate of progression (Grade A: slow, Grade B: moderate, Grade C: rapid). The disease has significant systemic implications, including bacteremia, endocarditis, and exacerbation of chronic kidney disease and diabetes mellitus.

The primary etiological agent is the polymicrobial biofilm of dental plaque, predominantly composed of Gram-negative anaerobic bacteria, including Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola, Fusobacterium nucleatum, and Prevotella intermedia. These bacteria possess virulence factors such as fimbriae, lipopolysaccharides (LPS), proteases (gingipains), and toxins that directly damage periodontal tissues and trigger host inflammatory responses. The host's immune response, particularly the release of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and matrix metalloproteinases (MMPs), contributes significantly to tissue destruction. Secondary etiological factors include dental calculus (mineralized plaque), which provides a rough surface for further plaque accumulation, and foreign body reactions to food impaction. In some cases, specific pathogens such as Pasteurella multocida and Streptococcus spp. may be involved. The disease is not contagious but is influenced by the oral microbiome composition, which is shaped by genetic and environmental factors.

Periodontitis is one of the most common diseases in companion animals, affecting approximately 80-85% of dogs and 70-75% of cats over three years of age. The prevalence increases with age, with severe periodontitis (Stage 3 and 4) seen in about 20-30% of dogs and 10-15% of cats. Breed predispositions include small and toy breeds (e.g., Yorkshire Terriers, Toy Poodles, Chihuahuas, Maltese) due to dental crowding and malocclusion, whereas large breeds (e.g., Greyhounds, Labrador Retrievers) are less affected. Cats, particularly brachycephalic breeds (e.g., Persians, Himalayans), are also at higher risk. No significant sex predilection is reported. Geographic variations are minimal, but indoor animals with poor oral hygiene and soft diets are more susceptible. The disease is more prevalent in animals with concurrent systemic diseases such as diabetes mellitus, chronic kidney disease, and immunosuppressive conditions.

The pathophysiology of periodontitis is a complex interplay between bacterial plaque and the host immune response. Initially, plaque accumulation leads to gingivitis, characterized by vasodilation, increased vascular permeability, and infiltration of neutrophils and macrophages into the gingival sulcus. As the biofilm matures, Gram-negative anaerobes dominate, releasing LPS and other virulence factors that stimulate Toll-like receptors (TLRs) on gingival epithelial cells and macrophages, triggering a cascade of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and chemokines. These mediators recruit more inflammatory cells, including T and B lymphocytes, and activate osteoclasts via the RANK-RANKL pathway, leading to alveolar bone resorption. Matrix metalloproteinases (MMPs), particularly MMP-8 and MMP-9, degrade collagen fibers of the periodontal ligament and gingival connective tissue, resulting in attachment loss and pocket formation. Chronic inflammation leads to fibrosis, reduced vascularity, and further bone loss. Systemic dissemination of bacteria and inflammatory mediators can cause bacteremia, endothelial dysfunction, and distant organ damage, contributing to conditions such as infective endocarditis, chronic kidney disease, and diabetes mellitus.

Intrinsic factors include genetic predisposition (e.g., small breed dogs with dental crowding), age (older animals have cumulative plaque exposure), and systemic diseases that impair immune function (e.g., diabetes mellitus, hyperadrenocorticism, chronic kidney disease). Extrinsic factors include inadequate oral hygiene (lack of tooth brushing), soft diets that do not provide mechanical cleaning, chewing habits (e.g., no access to dental chews), and environmental stress. Concurrent oral diseases such as malocclusion, retained deciduous teeth, and oronasal fistulas can predispose to plaque retention. Medications such as corticosteroids and cyclosporine can suppress immune responses and exacerbate periodontitis. Smoking (in humans) is not applicable, but passive smoke exposure in pets has been associated with increased risk.

Clinical signs vary with the stage of disease. In early stages (gingivitis), signs include mild gingival erythema, edema, and bleeding on probing. As periodontitis progresses, additional signs include halitosis, excessive drooling, difficulty chewing, pawing at the mouth, and visible calculus. In advanced stages, there may be gingival recession, periodontal pockets (depth >4 mm in dogs, >3 mm in cats), furcation exposure, mobile teeth, and tooth loss. Systemic signs may include fever, lethargy, anorexia, and weight loss. Chronic periodontitis can lead to oronasal fistulas (especially in small breeds), pathological fractures of the mandible, and osteomyelitis. In cats, chronic gingivostomatitis may coexist, causing severe oral pain and reluctance to eat.

Differential diagnoses include: (1) Gingivitis (reversible inflammation without attachment loss, distinguished by probing depths <3 mm and no radiographic bone loss); (2) Tooth root abscess (localized swelling, draining tract, and radiographic periapical lucency); (3) Eosinophilic granuloma complex (oral ulcers, proliferative lesions, histopathology shows eosinophilic infiltrate); (4) Oral neoplasia (squamous cell carcinoma, melanoma, fibrosarcoma; biopsy required); (5) Oronasal fistula (communication between oral and nasal cavities, often secondary to periodontitis); (6) Stomatitis (diffuse inflammation of oral mucosa, often immune-mediated, severe pain); (7) Foreign body (e.g., grass awn, bone fragment; imaging and oral exam); (8) Osteomyelitis (bone infection, radiographic changes, culture); (9) Trauma (fractured teeth, jaw fractures; history and imaging); (10) Autoimmune diseases (pemphigus vulgaris, systemic lupus erythematosus; skin lesions, biopsy, immunopathology).

The diagnostic algorithm begins with a thorough history and physical examination, including oral inspection and palpation. Under general anesthesia, a complete oral examination is performed using a periodontal probe to measure pocket depths, a dental explorer to detect subgingival calculus and furcation defects, and a dental mirror. Full-mouth dental radiographs are essential to assess alveolar bone loss, furcation involvement, periapical pathology, and tooth root abnormalities. Based on clinical and radiographic findings, periodontitis is staged and graded. Additional diagnostics may include: (1) Complete blood count and serum biochemistry to evaluate systemic health and rule out concurrent diseases; (2) Urinalysis and urine culture if systemic infection is suspected; (3) Blood pressure measurement to assess for hypertension; (4) Echocardiography if infective endocarditis is suspected; (5) Microbial culture and sensitivity from deep periodontal pockets in refractory cases; (6) Histopathology of gingival tissue if neoplasia or immune-mediated disease is suspected. The diagnosis is confirmed by the presence of attachment loss and bone loss on radiographs.

Hematology may reveal mild leukocytosis with neutrophilia in acute exacerbations, but is often unremarkable in chronic cases. Serum biochemistry may show elevated globulins (polyclonal gammopathy) due to chronic antigenic stimulation, and elevated liver enzymes (ALP, ALT) if systemic inflammation is present. In advanced cases, azotemia (elevated BUN, creatinine) may indicate concurrent chronic kidney disease. Urinalysis may show proteinuria (UPC >0.5) due to immune complex deposition. Blood gas analysis may reveal metabolic acidosis in severe systemic disease. Specific biomarkers: C-reactive protein (CRP) is often elevated, reflecting systemic inflammation; serum amyloid A (SAA) may also be increased. In cats, feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV) testing is recommended due to their association with oral disease. Periodontal pathogens can be detected via PCR from subgingival plaque samples, but this is not routinely performed.

Dental radiography is the primary imaging modality. Findings include horizontal and vertical bone loss, furcation involvement (visible as radiolucent areas at the furcation), widening of the periodontal ligament space, and periapical lucencies. In advanced cases, radiographs may show tooth root resorption, periapical abscesses, and pathological fractures. Computed tomography (CT) is useful for assessing the extent of bone loss and planning surgical interventions, especially in cases of oronasal fistulas or mandibular fractures. Magnetic resonance imaging (MRI) is rarely used but may be indicated for evaluating soft tissue involvement or neoplasia. Ultrasonography is not used for dental imaging but may be employed to assess cervical lymph nodes for metastasis if neoplasia is suspected. Thoracic radiographs are recommended if oral neoplasia is confirmed to rule out pulmonary metastasis.

Cytology of gingival exudate or fine-needle aspirates of oral masses may reveal inflammatory cells (neutrophils, macrophages, lymphocytes) and bacteria. Histopathology of gingival tissue is essential for differentiating periodontitis from other conditions. In periodontitis, histopathology shows chronic inflammatory infiltrate (lymphocytes, plasma cells, macrophages) in the lamina propria, epithelial proliferation, loss of collagen fibers, and bone resorption. Special stains (e.g., Gram stain) can identify bacterial types. If neoplasia is suspected, biopsy is mandatory. In cases of eosinophilic granuloma complex, histopathology reveals eosinophilic infiltrate and collagen degeneration. In autoimmune diseases, direct immunofluorescence may be performed.

Treatment of periodontitis involves professional dental cleaning (scaling and root planing) under general anesthesia, which removes plaque and calculus from supragingival and subgingival surfaces. This is followed by polishing to smooth the tooth surface and delay plaque reattachment. In cases of moderate to severe periodontitis, additional therapies include: (1) Local antimicrobial therapy: application of doxycycline gel (e.g., Doxirobe) into periodontal pockets; (2) Periodontal surgery: flap surgery for root planing and bone contouring, guided tissue regeneration using bone grafts or barrier membranes; (3) Extraction of severely affected teeth (if attachment loss >50%, furcation exposure, or mobility grade 2-3); (4) Antibiotic therapy: systemic antibiotics are indicated for aggressive or refractory cases, or when systemic signs are present. Commonly used antibiotics include amoxicillin-clavulanate (14 mg/kg PO q12h for 7-14 days), clindamycin (11 mg/kg PO q24h for 7-14 days), or metronidazole (10-15 mg/kg PO q12h for 7-10 days). Analgesics such as carprofen (2.2 mg/kg PO q12h for 3-5 days) or buprenorphine (0.01-0.02 mg/kg IV/IM q8-12h) are used for pain management. Supportive care includes a soft diet for 7-10 days post-operatively, oral hygiene instructions (daily tooth brushing, dental chews, chlorhexidine rinses), and regular dental re-checks. In cases of oronasal fistula, surgical closure is required. For severe stomatitis in cats, medical management with immunosuppressive doses of prednisolone (1-2 mg/kg PO q24h) or cyclosporine (5 mg/kg PO q24h) may be attempted, but extraction of premolars and molars is often curative.

The prognosis for periodontitis is generally good with appropriate treatment and owner compliance. Early stages (gingivitis, Stage 1) are reversible with professional cleaning and home care. Stage 2 and 3 periodontitis can be managed with regular dental prophylaxis and extractions of severely affected teeth, with a good long-term prognosis. Stage 4 periodontitis has a guarded prognosis for affected teeth, but overall quality of life can be maintained with extractions and supportive care. Negative prognostic indicators include advanced age, concurrent systemic diseases (e.g., diabetes, renal failure), immunosuppression, and lack of owner compliance with home care. Recurrence is common if oral hygiene is not maintained. In cats with chronic gingivostomatitis, prognosis is variable; many cats require full-mouth extractions to achieve remission.

Follow-up is essential to monitor disease progression and prevent recurrence. Re-check examinations should be performed at 3-6 month intervals for animals with moderate to severe periodontitis, and annually for those with mild disease. At each re-check, a complete oral examination under anesthesia is recommended to assess pocket depths, gingival inflammation, and radiographic bone loss. Serial dental radiographs should be taken every 6-12 months to monitor bone levels. Home care should be reinforced at every visit, including daily tooth brushing, use of dental diets (e.g., Hill's t/d, Royal Canin Dental), and dental chews. If systemic antibiotics were used, monitor for adverse effects and adjust dosages based on renal/hepatic function. In animals with concurrent diseases, regular monitoring of those conditions is necessary.

Pearls: (1) Always perform full-mouth dental radiographs in every dental patient, as radiographic findings often reveal more severe disease than clinical exam suggests. (2) Use a periodontal probe with gentle pressure (0.25 N) to avoid false pocket measurements. (3) In small breed dogs, be vigilant for oronasal fistulas, which may present as chronic nasal discharge. (4) Consider systemic antibiotics only when there is evidence of systemic involvement or aggressive periodontitis; routine use is not recommended. (5) Educate owners on the importance of daily tooth brushing; it is the gold standard for plaque control. Pitfalls: (1) Underestimating the severity of periodontitis without radiographs. (2) Failing to extract teeth with advanced attachment loss, leading to persistent pain and infection. (3) Overusing systemic antibiotics, contributing to antimicrobial resistance. (4) Neglecting to address underlying systemic diseases that may exacerbate periodontitis. (5) Inadequate pain management post-operatively, leading to anorexia and poor recovery.

Antimicrobials: Amoxicillin-clavulanate (Clavamox) 14 mg/kg PO q12h for 7-14 days; Clindamycin (Antirobe) 11 mg/kg PO q24h for 7-14 days; Metronidazole 10-15 mg/kg PO q12h for 7-10 days; Doxycycline (as local gel) applied to periodontal pockets at a dose of 10% doxycycline gel (e.g., Doxirobe) per manufacturer's instructions. Analgesics: Carprofen (Rimadyl) 2.2 mg/kg PO q12h for 3-5 days; Meloxicam (Metacam) 0.1 mg/kg PO q24h for 3-5 days (cats: 0.05 mg/kg PO q24h); Buprenorphine 0.01-0.02 mg/kg IV/IM q8-12h. Anti-inflammatories: Prednisolone 0.5-1 mg/kg PO q24h for 3-7 days (for severe inflammation); in cats with stomatitis, higher doses (1-2 mg/kg PO q24h) may be used. Immunosuppressants: Cyclosporine (Atopica) 5 mg/kg PO q24h for cats with stomatitis; Chlorhexidine oral rinse 0.12% applied to gingiva q24h. All dosages should be adjusted for renal or hepatic impairment; contraindications include hypersensitivity, pregnancy, and concurrent use of other hepatotoxic drugs. Drug interactions: Amoxicillin-clavulanate may reduce efficacy of oral contraceptives; metronidazole may potentiate anticoagulants.

Key studies and consensus guidelines: (1) The American Veterinary Dental College (AVDC) has established staging and grading guidelines for periodontitis, which are widely accepted. (2) A study by Niemiec (2008) in the Journal of Veterinary Dentistry reported that 80% of dogs and 70% of cats have periodontitis by age 3, emphasizing the need for early intervention. (3) A clinical trial by Rawlinson et al. (2013) demonstrated that daily tooth brushing significantly reduces plaque and gingivitis in dogs. (4) A meta-analysis by Stella et al. (2018) found that systemic antibiotics provide minimal additional benefit over professional cleaning alone in uncomplicated periodontitis, supporting judicious use. (5) The ACVIM consensus statement on antimicrobial use in small animals (2015) recommends against routine antibiotic use for periodontitis unless there is evidence of systemic infection. (6) A study by Southerden et al. (2017) showed that full-mouth extractions in cats with stomatitis result in remission in 60-80% of cases. (7) Research by Albuquerque et al. (2019) highlighted the association between periodontitis and chronic kidney disease in dogs, suggesting that periodontal treatment may improve renal outcomes. These findings underscore the importance of comprehensive dental care and the systemic impact of oral health.